Perhaps our data already constitute a potential mechanistic explanation to reports on increased childhood leukemia upon residential EMF exposure, as BIRC5 promotes cell proliferation and constitutes an important biomarker to predict the clinical outcome in AML patients [45]. The gene discussed is BIRC5; the disease is acute myeloid leukemia.